Prokarium

London, United Kingdom

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

Feb 2023

Series B

Top Investors

Wellcome TrustKorea Investment PartnersInnovate UKThe Future FundSynbiCITE

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Prokarium's investors?

Prokarium's investors include Wellcome Trust, Korea Investment Partners, Innovate UK, The Future Fund, SynbiCITE.

Where is Prokarium headquartered?

Prokarium is headquartered in London, United Kingdom.

What does Prokarium do?

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

What stage is Prokarium at?

Prokarium is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 9, 2023.

MLA

"Prokarium — Funding & Investors." VCBacked, February 9, 2023, https://www.vcbacked.co/company/prokarium. Accessed July 1, 2026.

APA

VCBacked. (2023). Prokarium — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/prokarium

Wikipedia (cite web)

{{cite web |title=Prokarium — Funding & Investors |url=https://www.vcbacked.co/company/prokarium |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 9, 2023.